Dr. Lockhart is an Associate Professor of Medicine in the Section of Medical Oncology and the Director of the Developmental Therapeutics Program for the Siteman Cancer Center. He joined the faculty of Washington University School of Medicine in 2008. His clinical interests are in the areas of new oncology drug development and cancers of the gastrointestinal (GI) tract. As the Director of the Developmental Therapeutics program for the Siteman Cancer Center, his aim is to assist in the development of novel anticancer therapies by conducting Phase I clinical trials. Also he has an interest in incorporating genomics into these studies to eventually personalize cancer treatment. Being a member of the GI oncology clinical team, he has a particular interest in cancers of the upper GI tract. In this regard, he helps to design and conduct clinical trials for patients with esophageal, gastroesophageal junction and gastric cancers.
Areas of expertise:
Gastroentestional cancer (anus, bile duct, colon, esophagus, gallbladder, pancreas, rectum, small intestine)